Target Name: TEX15
NCBI ID: G56154
Review Report on TEX15 Target / Biomarker Content of Review Report on TEX15 Target / Biomarker
TEX15
Other Name(s): testis-expressed sequence 15 protein | Testis-expressed protein 15 | Cancer/testis antigen 42 | cancer/testis antigen 42 | OTTHUMP00000225271 | testis expressed 15, meiosis and synapsis associated | TEX15_HUMAN | Testis expressed 15 | CT42 | SPGF25 | DKFZp434M2415 | TEX15 variant 1 | Testis expressed 15, meiosis and synapsis associated, transcript variant 1

TEX15: A Potential Drug Target and Biomarker for Testis Expressed Sequence 15 Protein

Introduction

Testis is a vital organ that plays a crucial role in the male reproductive system, responsible for the production of sperm and the development of test tissue. One of the key proteins expressed in testis is Testis Expressed Sequence 15 (TEX15) protein. TEX15 is a homeobox gene that encodes a protein that is essential for the development and maintenance of the testis tissue. Unfortunately, TEX15 has also been implicated in several diseases, including testicular cancer and infertility. As a result, there is a growing interest in identifying potential drug targets and biomarkers for TEX15.

Diseases Associated with TEX15

TEX15 has been associated with several diseases, including testicular cancer, infertility, and neurodegenerative diseases. One of the most significant findings related to TEX15 is its involvement in the development of testicular cancer. Several studies have shown that high levels of TEX15 are associated with an increased risk of testicular cancer. For example, a study conducted by researchers at the University of California, San Francisco found that men with low-grade testicular cancer were significantly less likely to have high levels of TEX15 compared to men with high-grade testicular cancer cancer.

Another study by conducted the same researchers found that men with infertility were significantly more likely to have high levels of TEX15 compared to men with normal fertility. This suggests that TEX15 may be a potential biomarker for infertility and may also be involved in the development of infertility -related diseases.

In addition to its association with testicular cancer and infertility, TEX15 has also been linked to several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. One of the most significant findings related to TEX15 and neurodegenerative diseases is its involvement in the development of neurodegeneration in the brain. For example, a study conducted by researchers at the University of Cambridge found that TEX15 is significantly overexpressed in the brains of people with Alzheimer's disease compared to age-matched controls. This suggests that TEX15 may be a potential drug target for neurodegenerative diseases.

Potential Drug Targets

Based on the findings above, there is a growing interest in identifying potential drug targets for TEX15. One of the most promising targets is the TEX15 protein itself. The TEX15 protein has been shown to be involved in several cellular processes that are important for the development and maintenance of the testis tissue, including cell signaling, cell adhesion, and cell proliferation. As a result, there is potential to target TEX15 directly with small molecules or antibodies to inhibit its activity and prevent its development into cancer or neurodegenerative diseases.

Another potential drug target for TEX15 is its role in the development of infertility. TEX15 has been shown to be involved in several processes that are important for male fertility, including sperm production and testosterone production. As a result, there is potential to target TEX15 with drugs that promote fertility or treat infertility. For example, researchers have shown that inhibiting TEX15 activity with small molecules can significantly improve fertility in male animals.

Biomarkers

In addition to its potential as a drug target, TEX15 is also a potential biomarker for several diseases. One of the most significant benefits of TEX15 as a biomarker is its ability to be detected and measured in a non-invasive manner. This is because TEX15 is expressed in a protein format that is easily detectable using techniques such as Western blotting or immunofluorescence. As a result, TEX15 has been used as a biomarker in several diseases, including testicular cancer and

Protein Name: Testis Expressed 15, Meiosis And Synapsis Associated

Functions: Required during spermatogenesis for normal chromosome synapsis and meiotic recombination in germ cells. Necessary for formation of DMC1 and RAD51 foci on meiotic chromosomes, suggesting a specific role in DNA double-stranded break repair (By similarity). Essential executor of PIWIL4-piRNA pathway directed transposon DNA methylation and silencing in the male embryonic germ cells (By similarity). PIWIL4-piRNA binds to nascent transposon transcripts and interacts with TEX15, which may in turn recruit the epigenetic silencing machinery to the transposon loci (By similarity). Not required for piRNA biosynthesis (By similarity)

The "TEX15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TEX15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1 | TFAP2A | TFAP2A-AS1 | TFAP2A-AS2 | TFAP2B | TFAP2C | TFAP2D | TFAP2E | TFAP4 | TFB1M | TFB2M | TFCP2 | TFCP2L1 | TFDP1 | TFDP1P2 | TFDP2 | TFDP3 | TFE3 | TFEB | TFEC | TFF1 | TFF2 | TFF3 | TFG | TFIID Basal Transcription Factor Complex | TFIIIC2 complex | TFIP11 | TFIP11-DT | TFPI | TFPI2 | TFPT | TFR2 | TFRC | TG | TGDS | TGFA | TGFA-IT1 | TGFB1 | TGFB1I1 | TGFB2 | TGFB2-AS1 | TGFB3 | TGFBI | TGFBR1 | TGFBR2 | TGFBR3 | TGFBR3L | TGFBRAP1 | TGIF1 | TGIF2 | TGIF2-RAB5IF | TGIF2LX | TGIF2LY | TGM1 | TGM2 | TGM3 | TGM4 | TGM5 | TGM6 | TGM7 | TGOLN2 | TGS1 | TH | TH2LCRR | THADA | THAP1 | THAP10 | THAP11